Overview:
A veterinary active pharmaceutical ingredient (API) is any chemical substance in a pharmaceutical drug that produces any desired effect in animals. Veterinary APIs can be a combination of two or more substances in a drug intended to provide some pharmacological effect. The veterinary APIs market is formidable in size and expected to escalate during the forecast period. The prominent factors that catalyze the growth of the global veterinary APIs market include increasing infrastructure and growing healthcare facilities for animal healthcare in both developed and developing countries. Furthermore, strategic initiatives by vendors, rising pet adoption, flexible regulations, unmet medical needs, and the outsourcing of veterinary API manufacturing fuel the growth of the global market.
Among the API types, in 2017, the antiparasitics segment dominated the global veterinary APIs market in terms of market value and was expected to retain its dominance during the forecast period. The dominance of antiparasitics is attributed to a large number of pharmaceutical industries, particularly those focused on antiparasitic APIs, as well as the widespread reporting of parasite infection in companion animals and cattle.
The trend in veterinary API production differs greatly from the trend in veterinary API consumption. Asia Pacific dominates the global market in terms of manufacturing APIs. Conversely, consumption of veterinary APIs is dominated by North America, owing to the presence of numerous pharmaceutical manufacturing companies in the region. Asia Pacific is identified as the most lucrative market segment owing to the growing adoption of pets and their treatment facilities.
The veterinary API market is highly fragmented due to the presence of numerous players competing in the market. The competition greatly influences the market in terms of pricing the APIs. Furthermore, there are instances of the illegal sale of APIs directly to pet owners to use as drugs, which negatively impacts the value chain.
The Veterinary Active Pharmaceutical Ingredients (APIs) Market is classified as follows:
Global Veterinary Active Pharmaceutical Ingredients Market, by API Type, 2016–2026 (US$ Mn)
- Antiparasitics
- Anti-infectives
- NSAIDs and anesthetics
- Others (beta antagonists, cardiovascular, gastroenterological, etc.)
Global Veterinary Active Pharmaceutical Ingredients Market by Geography (US$ Mn), 2016-2026
- North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- Rest of Europe
Asia Pacific
Latin America (LATAM)
- Brazil
- Mexico
- Rest of LATAM
Middle East and Africa (MEA)
Key players identified in the veterinary active pharmaceutical ingredients market include:
Ofichem BV, Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Changzhou Yabang Qh Pharmachem Co., Ltd., Eli Lilly & Co., Glenmark Pharmaceutical Limited, Indukern, S.A., P&R S.p.A. (Olon S.p.A.), Huvepharma AD, Orofino Saude Animal, Blanver Farmoquimica E Farmaceutica S.A., Sequent Scientific Ltd., NGL Fine-Chem Ltd., Omkar Speciality Chemicals Ltd., and Excel Industries Ltd.
This report offers the following:
- A comprehensive market outlook and future dynamics of the global veterinary active pharmaceutical ingredients market
- Elucidation of the global veterinary active pharmaceutical ingredients market at a granular level through market segmentation based on various parameters
- Market estimations of the global veterinary active pharmaceutical ingredients market for the span of 10 years from 2016 to 2026 are provided, which quantify the growth of the market during the forecast period.
- Profiling of the key players operating in the veterinary active pharmaceutical ingredients market, along with graphical positioning of the major players
